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ABSTRACT
Objective: Thymic function declines exponentially with
age. Impaired thymic function has been associated with
autoimmune disease in adults but has never been formally
assessed in childhood autoimmunity. Therefore, thymic
function in children with the autoimmune disease juvenile
idiopathic arthritis (JIA) was determined.
Methods: Thymic function was measured in 70 children
and young adults with JIA (age range 2.1–30.8 (median
10.4)) and 110 healthy age-matched controls using four
independent assays. T cell receptor excision circles
(WBLogTREC/ml) and the proportion of CD4
+
CD45RA
+CD31
+ T cells (representing recent thymic
emigrants; %RTEs) were quantified and intrathymic
proliferation measured by calculating the aTREC/SbTREC
ratio. Lastly, regulatory T cells (TReg) of thymic origin
(CD4
+FOXP3
+) were quantified in peripheral blood to
assess the ability of the thymus in JIA to generate this T
cell subset.
Results: Thymic function was equivalent by all four
parameters in JIA when compared with the control
population. Furthermore, there was no consistent effect of
JIA subtype on thymic function, although intrathymic
proliferation was higher in the small rheumatoid factor
(RF)
+ polyarticular group. There were no significant effects
of disease-modifying antirheumatic drugs (DMARDs) or
oral corticosteroids on thymic function, although those
with the worst prognostic ILAR (International League of
Associations for Rheumatology) subtypes were also those
most likely to be on a DMARD.
Conclusions: It is demonstrated that children and young
adults with JIA, unlike adults with autoimmune diseases,
have thymic function that is comparable with that of
healthy controls. The varied pathologies represented by
the term ‘‘JIA’’ suggest this observation may not be
disease specific and raises interesting questions about the
aetiology of thymic impairment in adult autoimmunity.
The thymus plays a critical role in the development
of normal immune tolerance.
1 As well as negatively
selecting potentially autoreactive T cells, it also
positively selects the naturally occurring regulatory
T cell subset (TReg) (CD4
+FOXP3
+).
2 Cross-sec-
tional studies have demonstrated impaired thymic
function in several adult autoimmune diseases.
3–6 It
remains unclear whether the thymic defect is
primary or secondary, although single gene defects
affecting thymic integrity can predispose to auto-
immunity.
78In contrast to adults, thymic function
has not been formally quantified in childhood
autoimmunity such as juvenile idiopathic arthritis
(JIA).
The normal thymus is largest in childhood and is
well known to decline in size and function with
increasing age.
9 Whilst not normally of apparent
consequence, this decline becomes important
under circumstances where the T cell pool is
depleted, such as in HIV-AIDS or during lympho-
ablative treatments such as bone marrow trans-
plant or stem cell transplantation (SCT). This
(normal) decline in thymic function with ageing is
thought to explain the slower and often less
complete T cell reconstitution following SCT in
adults when compared with that in children.
10 11
JIA describes a heterogeneous group of diseases
12
ranging in severity from severe polyarticular
disease sometimes associated with systemic fea-
tures, to more benign oligoarticular disease. The
more severe JIA subtypes have a poor prognosis,
with lack of response to intense immunosuppres-
sion in some cases.
13 14 Autologous SCT has
recently been shown to induce prolonged, drug-
free remission in a proportion of such refractory
patients.
15
Measuring thymic function in humans is com-
plicated by the lack of a specific phenotype for
recent thymic emigrants (RTEs), although the
surface profile CD4
+CD45RA
+CD31
+ has been
proposed as a potential marker.
16 Rearrangement
of the T cell receptor a chain (TCRa) gene results
in the formation of an episome of DNA called a ‘‘T
cell receptor excision circle’’ (TREC).
17 TRECs are
present only in thymically derived T cells and do
not divide with cellular mitosis. When quantified
per millilitre of whole blood, TRECs are widely
accepted to be the optimal measurement of thymic
function.
18
In the current study we compare thymic
function in children with JIA and healthy controls.
By measuring TRECs, the proportion of
CD4
+CD45RA
+CD31
+ T cells and TReg in periph-
eral blood, and intrathymic T cell development
using a novel assay, we demonstrate that thymic
function is not compromised in JIA.
PATIENTS AND METHODS
Study subjects
Following ethical approval and informed consent
from the child and/or a parent or guardian, 9 ml
blood samples were obtained from healthy control
children undergoing simple surgical procedures.
Samples from young adults were donated by
healthy volunteers. Study subjects were consecu-
tive attendees at the Newcastle Regional Paediatric
Rheumatology Service in Newcastle. All were given
a diagnosis of JIA classified according to the ILAR
(International League of Associations for
Rheumatology) classification by a consultant
Paediatric Rheumatologist.
12 Samples from older
patients were obtained at adolescent and young
adult rheumatology clinics. Blood was collected
into Vacuette EDTA K3 tubes (Greiner Bio-one,
Kremsmu ¨nster, Austria).
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DNA was extracted from 300 ml of whole blood using the
Wizard Genomic DNA extraction kit (Promega, Madison,
Wisconsin, USA) and stored at 4uC. Sample purity and quantity
was determined by spectrophotometry (Nanodrop ND-100,
Wilmington, Delaware, USA).
TREC quantification
We have developed a method quantifying TRECs/ml in DNA
extracted from 300 ml of whole blood
19. Briefly, WBLogTREC/
ml is determined from a simultaneously amplified standard
curve (range 10
7–10
1 TREC molecules) using quantitative real-
time PCR (RQ-PCR), an ABI Prism 7900HT Sequence Detector
System and SDS2.2 software (Applied Biosystems, Warrington,
UK).
Reactions (25 ml) contained primers CACATCCCTTTCAA
CCATGCT and GCCAGCTGCAGGGTTTAGG both at
700 nM, 150 nM Taqman hydrolysis probe (6-FAM-ACACCT
CTGGTTTTTGTAAAGGTGCCCACT-TAMRA), 12.5 mlo f
JumpStart Taq ReadyMix (Sigma, Poole, UK) and 200 ng of
DNA. Thermal cycling conditions were 50uC for 2 min then
95uC for 10 min, then 40 cycles of 95uC for 15 s and 60uC for
1 min. Experimental samples were run in duplicate and
averaged.
Quantification of intrathymic proliferation
Intrathymic proliferation was measured using a modified
version (to allow for use with SYBR Green) of the method
published by Dion et al.
20 Ten TCRb chain DbRJb rearrange-
ments (bTRECs) and the TCRa chain drecRyJa rearrangement
(aTRECs) were quantified in separate, nested PCRs. A duplex
first round reaction with primers for individual bTRECs and
genomic CD3 was followed by individual RQ-PCRs. The CD3
copy number multiplied by 0.5 (since each cell contains two
copies) allowed the bTREC frequency to be reported per 10
5
cells.
First-round 25 ml PCRs contained 16 High Fidelity PCR
buffer (Invitrogen, Paisley, UK), 0.2 mM each of dNTPs
(Invitrogen), 1.5 mM MgCl2 (Invitrogen), 1 U of Platinum
Taq High Fidelity (Invitrogen), 500 nM of both primers (Sigma
Genosys, UK) and 150 ng of target DNA. Initial denaturation
was at 95uC for 10 min followed by 22 cycles of 95uC for 30 s
and 72uC for 30 s. Second-round, 25 ml reactions contained 26
SybrGreen PCR Master Mix (TAKARA, Berkshire, UK), 400 nM
of each primer (Sigma Genosys) and 10 ml of template. Thermal
cycling conditions were 95uC for 10 s followed by 40 cycles of
95uC for 5 s and 60uC for 60 s.
Surface staining of peripheral blood mononuclear cells (PBMCs)
for quantification of recent thymic emigrants
A7 0ml aliquot of whole blood was incubated in the dark at
room temperature for 15 min, with combinations of antibodies
to surface antigens: CD31–PE (phycoerythrin), CD45RA–FITC
(fluorescein isothiocyanate; Serotec, Oxford, UK) and CD4–PE–
Cy5 (Beckton Dickinson, Oxford, UK). Stained samples were
incubated with 16FACS Lyse Solution (Beckton Dickinson) for
10 min and washed twice.
Isolation of PBMCs from whole blood and intracellular cell
staining
PBMCs were isolated according to a standard, sucrose density
gradient (Lymphoprep) protocol and cryopreserved in 10%
dimethylsulfoxide (DMSO) in fetal calf serum (FCS) at 280uC
until use. Thawed cells were surface stained with CD4
+–
FITC and then FOXP3–APC (allophycocyanin) antibody
(eBiosciences, Wembley, UK) according to the manufacturer’s
instructions. Flow cytometry was performed using a FACScan
and data were analysed using FloJOv6.1.2. Sample identities
were blinded to the assessor.
Statistical analysis
Statistical analyses were performed using SPSS 11th edition
software. Values for WBLogTREC/ml were initially log trans-
formed to allow parameteric testing. Population distributions
were tested for normality with a one-sample Kolmogorov–
Smirnov test. Correlations for normally distributed data were
tested for significance using Pearson’s correlation coefficient.
Differences between groups were assessed by analysis of
covariance (ANCOVA) where other covariates were present,
unless otherwise stated. Bonferroni corrections were applied to
correct for multiple comparisons. Results were considered
significant when p(0.05.
RESULTS
Thymic function declines with age throughout childhood and
does not differ between patients with JIA and healthy controls
WBLogTREC/ml was quantified in 70 patients with JIA and 110
healthy controls (HCs). Table 1 describes the cohort. One
additional patient had DiGeorge syndrome (chromosome 22q11
deletion-associated syndrome with thymic hypoplasia/aplasia)
and a co-existing inflammatory arthritis. Figure 1A shows that
there was no significant difference in thymic function between
the groups after adjusting for age and gender (see below).
Negative correlations with age were detected for both groups
(p,0.01). The patient with DiGeorge syndrome had markedly
deficient thymic function as evidenced by a 1.5Log deficit in
WBLogTREC/ml when compared with age-matched controls.
There was no difference in thymic function when ILAR JIA
subtypes were compared (fig 2A).
The proportion of CD4
+CD45RA
+CD31
+ declines with age in HCs
and patients with JIA
CD4
+CD45RA
+CD31
+ T cells are TREC rich and have been
proposed as the phenotype of RTEs in humans.
16 The
proportion of T cells with this phenotype (%RTEs) declined
with age in patients with JIA (n=50) and HCs (n=77) (fig 1B),
but there was no significant difference in age-adjusted mean
%RTEs.
Since both WBLogTREC/ml and %CD4
+CD45RA
+CD31
+ T
cells have been proposed as markers of thymic function, there
should be a strong positive correlation between them, indepen-
dently of disease status. Although the relationship was strong in
HCs (r=0.71; p,0.01), it was less robust in patients with JIA
(0.45; p,0.01). There was no effect of ILAR subtype on %RTEs
(fig 2B).
In our patient with DiGeorge syndrome, the %RTEs was
normal despite a significantly reduced WBLogTREC/ml value
(fig 1B), suggesting that CD4
+CD45RA
+CD31
+ T cells may be
capable of self-renewal in the absence of thymic replenishment.
Gender differences in thymic function are preserved in children
with JIA
In both mice and adult humans, females have a larger thymic
output (as determined by TREC quantification and histological
analysis of thymic volume) than age-matched males.
21 22
Using the two assays described above, we confirmed higher
Extended report
984 Ann Rheum Dis 2009;68:983–990. doi:10.1136/ard.2008.088112Table 1 Patient characteristics according to ILAR subtype
n Age/years, median (range) Male (%)
DMARD any
(%) MTX (%) Biologic* (%)
Oral steroid
(%) No DMARD{
Systemic onset 8 10.52 (3.51–15.12) 6 (75) 7 (88) 5 (63) 3 (38) 3 (38) 1 (12.5)
Polyarticular RF
+ 10 9.92 (4.11–17.85) 3 (30) 7 (70) 6 (60) 1 (10) 3 (38) 2 (20)
Polyarticular RF
2 12 12.59 (2.85–15.13) 2 (16) 7 (58) 6 (50) 2 (17) 3 (38) 5 (41)
Persistent
oligoarticular
27 9.16 (2.06–28.74) 7 (27) 2 (7) 2 (7) 0 0 25 (93)
Extended oligoarticular 7 10.3 (4.03–17.96) 2 (28) 4 (57) 1 (14) 3 (43) 0 3 (43)
Psoriatic 4 19.3 (14.36–30.78) 3 (75) 2 (50) 1 (25) 1 (25) 1 (25) 2 (50)
Enthesitis 2 14.25 (12.8–15.69) 1 (50) 2 (100) 2 (100) 0 1 (50) 0
*Includes antitumour necrosis factor a agents and interleukin 1 receptor antagonist (IL1ra).
{Includes those taking only non-steroidal anti-inflammatorry drugs (NSAIDs) or relying only on local joint injections for disease control.
RF, rheumatoid factor; DMARD, disease-modifying antirheumatic drug; ILAR, International League of Associations for Rheumatology; MTX, methotrexate.
Figure 1 Thymic function is not significantly different in children with juvenile idiopathic arthritis (JIA) (grey diamonds, dashed regression line) and
healthy controls (HCs) (filled squares, solid regression line) when quantified using WBLogTREC/ml (T cell receptor excision circles) (A) and by the
proportion of T cells with the phenotype CD4
+CD31
+CD45RA
+ (%RTE (recent thymic emigrants)) (B). WBLogTREC/ml was significantly negatively
correlated with age (r=20.762; p,0.001 for controls and r=0.625; p,0.001 in JIA) as was %RTE (r=20.656; p,0.001 and r=0.491; p,0.001
respectively). In a single patient with co-existent DiGeorge syndrome (grey triangle with dashed circle surround), TREC levels were markedly reduced,
but %RTE was age appropriate. In both HCs (C) and the JIA group (D), females (grey diamonds, dashed regression lines) have greater thymic function
than males (filled squares, solid regression line) using WBLogTREC/ml (p=0.002 and p=0.003 respectively).
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patients with JIA (fig 1C,D). The age-adjusted mean
WBLogTREC/ml value for HC females (n=51) was 5.039 and
for males (n=59) 4.985 (p=0.002); in the JIA group, the
comparable figures were 5.004 (n=46) and 4.826 (n=24),
(p=0.003).
Using %RTEs, a gender difference was again detected in HCs
(age-adjusted mean %RTEs in females (n=36) 52.9%, males
(n=41) 45.6% (p=0.001) but not in the JIA group (data not
shown).
Effect of immunosuppressant therapy on thymic function in JIA
Corticosteroids and some immunosuppressive treatments have
been considered to inhibit thymic function,
23–25 and we therefore
sought an effect in JIA. It should be noted that the majority of
children taking DMARDs or oral corticosteroids had more
severe disease, falling into the systemic-onset, polyarticular and
extended oligoarticular subtypes (see table 1). However, when
patients receiving these drugs were compared with those not
receiving them and with healthy controls using WBLogTREC/
ml, no evidence of a significant effect of DMARDs (when
considered collectively (n=31)) (4.874 vs 4.933 vs 4.985) (fig 3A)
or corticosteroids (¡ DMARD) (n=11) (4.818 vs 4.924 vs
4.985) was found (data not shown). There was, however, a
trend toward lower WBLogTREC/ml values in patients with
JIA on a DMARD (p=0.061) and those taking steroids
(¡ DMARD) (p=0.07) when compared with HCs. There
was no effect of taking methotrexate (MTX) on WBLogTREC/
ml values (4.887) when compared with those not on MTX
(4.917) and with HCs (4.985) (p=NS) although some patients
not on MTX were taking an alternative DMARD (primarily
antitumour necrosis factor a (TNFa)) (n=8). Other treatment
groups contained too few patients to exclude an independent
effect. In contrast, after adjustment for age and gender, %RTEs
was significantly higher in patients on oral corticosteroids
(n=8; 58.3%) than in those not on oral corticosteroids (n=40;
47.0%; p=0.013), and the comparison with HCs (n=77)
approached significance (49.8%; p=0.067). There was no
difference between those not on oral corticosteroids and HCs.
There was no significant effect of DMARD use (fig 3B) or MTX
specifically on %RTEs.
Figure 2 Thymic function does not significantly differ between
International League of Associations for Rheumatology juvenile idiopathic
arthritis (JIA) subtypes when measured using either WBLogTREC/ml (T
cell receptor excision circles) (A) or %RTE (recent thymic emigrants)
(p=NS) (B). Bars represent age-adjusted group means (SEM). Groups
were compared using analysis of covariance with age as a covariate and
multiple comparisons corrected for by performing a Bonferroni
correction. PolyRF+ and PolyRF–, polyarticular rheumatoid factor
positive and negative, respectively; PsA, psoriatic; Enth, enthesitis
associated; Ext oligo, extended oligoarticular; Persis oligo, persistent
oligoarticular).
Figure 3 There was no significant effect on thymic function when
measured using WBLogTREC/ml (T cell receptor excision circles) (A) or
%RTEs (recent thymic emigrants) (B) of being on a disease-modifying
antirheumatic drug (DMARD). Bars represent age- and gender-adjusted
group means (SEM). Groups were compared by analysis of covariance
with a Bonferroni correction to adjust for multiple comparisons. Patients
not on a DMARD were more likely to have persistent oligoarticular
disease than those taking one; see table 1. There was a trend toward
lower WBLogTREC/ml values in those taking a DMARD (p=0.061)
when compared with healthy controls (HCs). *Includes those taking only
non-steroidal anti-inflammatory drugs or relying only on local joint
injections for disease control. **DMARDs include antitumour necrosis
factor a agents and interleukin 1 receptor antagonist (IL1ra).
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When the TCRa chain gene rearranges, the locus encoding the
TCRd chain is excised in a conserved rearrangement, resulting in
the formation of a TREC that can be identified in approximately
70% of emerging thymocytes. This rearrangement is the basis of
most standard TREC assays, including our own WBLogTREC/ml
assay.
17 When the TCRb chain gene is rearranged, no single
rearrangement occurs, but there are only 13 potential DbRJb gene
rearrangements.
26 Dion et al devised an assay that quantifies 10 of
these 13 TREC-generating rearrangements, the sum of which
providesanestimateofthefrequencyofT cellsinperipheralblood
that have rearranged their TCRb chain gene (SbTREC).
20 TCRa
chain rearrangement occurs after TCRb chain rearrangement.
Between these events a phase of thymocyte proliferation expands
thymocytes with a rearranged TCRb chain, providing a substrate
for the subsequent generation of TCR diversity through a chain/b
chain pairing. The ratio between the numbers of T cells
containing detectable TCRb and TCRa chain rearrangements
(aTREC:SbTREC) therefore gives an indication of the number of
divisions, which is a measure of intrathymic proliferation and
overall thymic function.
We determined intrathymic function in patients with JIA and
HCs. No difference was found when 19 children with JIA were
compared with 19 HCs, and there was also no detectable effect
of gender (data not shown). There were insufficient samples to
seek an effect of corticosteroids or DMARDs. The effect of ILAR
subclassification was assessed. There were no significant
differences between the groups after post hoc testing, with
the exception of all comparisons with the polyarticular RF
+
group (n=3) which (after the two groups where n=1 were
excluded) achieved statistical significance (fig 4A). The true
significance of this result is difficult to assess because of small
patient numbers, and was lost when we combined together the
poor prognosis subtypes of systemic onset, polyarticular and
extended oligoarticular JIA (‘‘non-oligoarticular’’, n=9) and
compared with persistent oligoarticular JIA (‘‘oligoarticular’’
n=11), a classification previously used
27 (fig 4B).
In the patient with DiGeorge syndrome, the aTREC:SbTREC
ratio was 57 in comparison with the HC group median (352)
and the JIA group median (628), reflecting the impaired
structural environment of the DiGeorge thymus and its reduced
capacity for thymocyte expansion. The SbTREC value in this
patient was comparable with JIA values 1.58 vs 5.38 (range
0.53–17.41), whereas the aTREC value was significantly
reduced, 91 vs 3002 (range 851–5065). This implies that
thymocyte proliferation is impaired in DiGeorge syndrome in
comparison with HCs and children with JIA.
Thymus-derived TReg are more frequent in persistent
oligoarticular JIA
Lastly, we quantified the proportion of CD4
+ T cells with the
regulatory phenotype CD4
+FOXP3
+ (TReg). There was no
detectable difference overall between patients with JIA and
HCs. When individual ILAR subtypes were compared, there was
a weak but significant difference between the patients with
systemic and persistent oligoarticular disease (p=0.031) in a
post hoc analysis, although sample sizes were again small
(table 2). To strengthen our analysis by increasing group
numbers, patients with ‘‘non-oligoarticular’’ disease (as above)
were compared with patients with persistent oligoarticular
disease. We found a significant increase in the proportion of
TReg in the oligoarticular group (8.19% vs 6.481%; p=0.044,
Tukey HSD post hoc analysis), consistent with other reports.
Unlike those reports, however, there was no difference from
HCs. There was no effect of gender, age or DMARD use,
although MTX use was more common in non-oligoarticular JIA
(see table 1), potentially confounding the difference between
disease subtypes.
DISCUSSION
Our data demonstrate that, in children with JIA, thymic
function is comparable with that of healthy control children.
This conclusion is strengthened by our analysis of multiple
aspects of thymic function, including intrathymic proliferation
Figure 4 (A) The ratio between the numbers of T cells containing detectable T cell receptor b (TCRb) and TCRa chain rearrangements
(aTREC:SbTREC) (y-axis) was compared between International League of Associations for Rheumatology subtypes using analysis of covariance with
Bonferroni correction for multiple comparisons, with age and gender as covariates because of their effect on the aTREC (T cell receptor excision circle)
value. When the two subsets where n=1 were excluded, the comparisons between the polyarticular rheumatoid factor (RF)
+ group and the reminder
were statistically significant (p,0.05)—although caution should be applied to the interpretation of this result given the small group numbers. Sys,
systemic (n=3); PRF
+ and PRF
2, polyarticular RF
+/polyarticular RF
2 (n=3 both groups); PsA, psoriatic (n =1); ExO, extended oligoarticular (n=1);
PerO, persistent oligoarticular (n=8). (B) When grouped into persistent oligoarticular disease and non-oligoarticular disease (see text), there were no
significant differences between the groups. Boxes represent the interquartile ranges (IQR) and bars the group medians. Whiskers give the data range,
with ‘‘N’’ representing extreme values (.3 IQR from the box end). HC, healthy controls.
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previous reports, we have demonstrated greater thymic func-
tion in females
28 and an age-associated decline in healthy
controls,
29 findings that persist in JIA. In a single patient with
inflammatory arthritis and co-existent DiGeorge syndrome, we
showed a dramatic reduction in thymic function, consistent
with thymic hypo/aplasia and similar to the effect of partial
thymectomy during paediatric cardiac surgery.
30 Although we
have previously confirmed that consecutive recruitment of
patients from our clinic population provides a group of patients
with a typical case mix
31 (table 1), the short recruitment period
(4 months) may have biased our population toward those with
more severe disease (since they are more likely to attend
hospital).
When data were analysed according to ILAR disease subtype,
a minority of comparisons reached statistical significance or
demonstrated a trend in that direction. For example, there was a
trend toward reduced thymic function for those on a DMARD
(although since disease group and DMARD use co-segregate,
this analysis is confounded by ILAR subtype), and steroid use
was associated with an increase in the %RTEs. The
aTREC:SbTREC ratio was increased in the ILAR polyarticular
RF
+ group, whilst the persistent oligoarticular group had a
significantly higher proportion of TReg than the ILAR systemic
disease group, consistent with previous reports. These isolated
observations should be interpreted with caution due to the
small group numbers, and they require further analysis in a
larger study in order to determine their true significance.
T cells with the phenotype CD4
+CD45RA
+CD31
+ have
significantly higher TREC content per cell than unselected
CD4
+ T cells,
16 confirming that this subset is enriched for true
thymic emigrants. Furthermore, CD4
+CD45RA
+CD31
+ T cell
telomeres are longer and telomerase activity higher than in
CD4
+CD45RO
+CD31
+ T cells, suggesting a limited replicative
history.
32 This phenotype has been used to monitor thymic
function longitudinally
33–35 and, although interindividual varia-
tion is high, values are stable longitudinally
35 (ARL and JDI,
unpublished results). Thus, it was interesting to note that,
despite an ,1.5Log deficit in WBLogTREC/ml in a patient with
DiGeorge syndrome, the proportion of CD4
+CD45RA
+CD31
+ T
cells was age appropriate. Furthermore, WBLogTREC/ml and
%RTEs did not always correlate well, particularly in disease
(lending support to the recent observation that
CD4
+CD45RA
+CD31
+ T cells can in part be maintained by
peripheral homeostasis
36), and thus may represent a less useful
measure of thymic function in this setting. Naı ¨ve T cells
proliferate excessively in patients with rheumatoid arthritis
(RA), possibly under cytokine stimulation.
37 A similar phenom-
enon in JIA would weaken the correlation between
CD4
+CD45RA
+CD31
+ T cells and WBLogTREC/ml, as we have
shown here.
Regardless of its indication, adults fare less well than children
following autologous SCT (ASCT).
38 In part this reflects an
inverse relationship between age and CD4
+ T cell reconstitu-
tion
39 40 but, in autoimmunity, disease-related thymic compro-
mise may exacerbate the distinction. For example, patients with
RA remain lymphodepleted for years following ASCT,
41 but
disease usually relapses rapidly despite persisting lymphopenia.
In contrast, patients with JIA reconstitute more rapidly and,
moreover, thymically derived TReg may contribute to long-term
remission of symptoms.
42 Thus, measures aimed at reversing
age-associated thymic atrophy (currently in clinical trial
43 44)
could significantly improve the outcome of ASCT in adults with
autoimmune diseases.
The normal thymus produces T cells that are self-tolerant,
with a polyclonal TCR repertoire. Age-related thymic involu-
tion results in a proportionally greater decline in thymocytes
with rearranged TCRa genes than with TCRb chain genes,
20
with potential implications for repertoire diversity,
45 and there-
fore the maintenance of self-tolerance, responses to neoantigens
and tumour surveillance.
46 We determined a ratio that reflected
the number of cellular divisions between these two events. The
similarity between patients (when collectively considered) and
controls suggests that this step in thymocyte development is
intact in JIA. When individually considered, however, there was
a significant increase in the ratio for the polyarticular RF
+
patients. A single extreme value contributes to this effect, but
the remaining two individual values were also greater than for
all other subtypes (fig 4A), a consequence of both low bTREC
and high aTREC values (data not shown). The significant
contribution of the aTREC value to the ratio and the variance of
this value in both patients with JIA and HCs (fig 1) should also
be noted, and duplication of our results is required before
further conclusions about this difference can be drawn. If
confirmed, however, this result would suggest enhanced
intrathymic proliferation in the JIA subtype that most closely
resembles adult RA, in which there is evidence of impaired
thymic function.
3 TCR diversity and TRECs are positively
correlated,
47 suggesting that the TCR repertoire in JIA is also
likely to be maintained.
De Kleer et al distinguished two subsets of TReg in JIA
peripheral blood following ASCT.
42 Expansion of mature, non-
depleted or grafted TReg in the lymphopenic environment was
followed 6–8 months later by the appearance of TReg of recent
thymic origin (which may have greater suppressive function
than memory CD45RO
+ TReg
48), together replenishing the
depleted pretransplant TReg pool.
42 Although we did not
distinguish TReg subsets, we found a higher proportion of TReg
in persistent oligoarticular disease than in non-oligoarticular
disease although we could not confirm a difference between
either group and HCs, possibly reflecting our use of FOXP3 to
quantify TReg, rather than CD25
bright.
42 We have previously
shown that adults with self-limiting reactive arthritis have a
higher proportion of TReg than adults with RA,
49 and murine
studies have demonstrated that Foxp3
+ T cells protect against
autoimmune disease and inflammation in vivo.
50 Collectively,
these data suggest that control of inflammatory disease may be
associated with this subset of T cells. Indeed, all four patients
Table 2 Mean values for %CD4
+FOXP3
+ and 95% CI for the ‘‘non-
oligarticular’’ group (comprising systemic, polyarticular RF
+ and RF
–, and
extended oligoarticular ILAR categories), the persistent oligoarticular
group and a healthy control group
n
%CD4
+FOXP3
+
(mean) 95% CI
Non-oligoarticular* 27 6.48 5.54 to 7.43
Systemic{ 4 4.79 2.31 to 7.27
Polyarticular RF
+ 7 7.32 5.44 to 9.20
Polyarticular RF
– 10 6.57 5.00 to 8.14
Extended oligoarticular 6 6.49 4.45 to 8.51
Persistent oligoarticular*{ 22 8.19 7.00 to 9.39
Healthy controls 33 6.91 6.05 to 7.78
*When individual ILAR subtypes were compared there was a significant difference
between the systemic and persistent oligoarticular ILAR subtypes (p=0.031);
Games–Howell post hoc test analysis (which accounts for the differing group sizes).
{Regulatory T cells (TReg ) were significantly higher in the persistent oligoarticular
group when compared with the non-oligoarticular group (p=0.044) but not healthy
controls (p=0.720).
ILAR, International League of Associations for Rheumatology; RF, rheumatoid factor.
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TReg in peripheral blood. However, their otherwise normal
thymic function suggests that their TReg deficit may reflect a
failure of peripheral TReg homeostasis in progressive, chronic
disease.
In conclusion, using a variety of measurements, we have
demonstrated age-appropriate thymic function in patients with
JIA. We found no clear influence of therapy on thymic function,
although DMARD use was more common in patients with JIA
with a poor prognosis and was associated with trends toward
lower WBLogTREC/ml values. We also found similar TReg
values in HCs and patients with JIA, although patients with JIA
of the better prognosis subtype had higher values. Our findings
differ from those in adult patients with autoimmune disease, in
whom thymic dysfunction has been implicated as a possible
aetiological factor.
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